|
TTC7B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.933400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.579600E-01 |
| Normal-vs-Stage2 |
4.541400E-03 |
| Normal-vs-Stage3 |
6.615800E-01 |
| Normal-vs-Stage4 |
1.984950E-01 |
| Stage1-vs-Stage2 |
5.841300E-03 |
| Stage1-vs-Stage3 |
5.234600E-01 |
| Stage1-vs-Stage4 |
1.780210E-01 |
| Stage2-vs-Stage3 |
3.877700E-03 |
| Stage2-vs-Stage4 |
1.357580E-03 |
| Stage3-vs-Stage4 |
4.812800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.061200E-01 |
| Normal-vs-AfricanAmerican |
6.328800E-01 |
| Normal-vs-Asian |
6.113600E-01 |
| Caucasian-vs-AfricanAmerican |
8.612000E-01 |
| Caucasian-vs-Asian |
3.750400E-01 |
| AfricanAmerican-vs-Asian |
4.651200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.402000E-01 |
| Normal-vs-Female |
2.668200E-01 |
| Male-vs-Female |
2.402400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.241600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.131200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.605600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.136800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.713000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.589800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.859600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.644200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.092600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.948090E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.436000E-01 |
| Classical-VS-Follicular |
3.05830000002505E-06 |
| Classical-VS-Other |
6.426000E-01 |
| Classical-VS-Normal |
6.509600E-02 |
| Tall-VS-Follicular |
1.02229999998649E-06 |
| Tall-VS-Other |
5.272800E-01 |
| Tall-VS-Normal |
1.604280E-02 |
| Follicular-VS-Other |
2.181200E-01 |
| Follicular-VS-Normal |
1.002640E-04 |
| Other-VS-Normal |
9.827800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.571500E-02 |
| Normal-vs-N1 |
9.900500E-03 |
| N0-vs-N1 |
6.23410000000213E-05 |
|
|
